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EDITORIAL
Stem Cells and Cloning: What’s the Difference
and Why the Fuss?
As a writer of embryology text-books, I find myself regularlywishing that my latest book
hadn’t gone to press just a month
before the most recent major break-
through in embryotechnology. This
year, the cause celebre was the twin
announcements of the production of
human embryonic stem cells derived
from the inner cell mass of the blasto-
cyst6 or from primordial germ cells
taken from 5-to-9-week-old human em-
bryos.4 These reports, coupled with
the news account of an announcement
that a private biotech company in
Massachusetts (Advanced Cell Tech-
nology) claims to have produced em-
bryonic stem cells by fusing a buccal
epithelial cell of a human with the
enucleated oocyte of a cow,7 have
spawned numerous articles and edito-
rials that simultaneously extol the tech-
nological leaps and decry our collec-
tive inability to provide an ethical basis
for such work.
For at least the next few years, the
public image of cloning will continue
to be the indelible imprint of Dolly, the
impassive sheep that was generated by
fusing a mammary epithelial cell with
an enucleated egg. Dolly, by the way,
has by now produced a normal off-
spring of her own in the old-fashioned
way.
In the popular press, the distinction
between stem cell technology and clon-
ing is often blurred. Yet, despite super-
ficial similarities in certain aspects of
technique, the goals and processes are
quite different. A fundamental biologi-
cal unifying factor, however, is the fact
that the nuclei of most cells in both
embryos and adults contain a full
complement of genetic information.
As normally understood, cloning
consists of fusing the nucleus of a
donor cell (or the whole cell in the case
of Dolly) with an enucleated oocyte.
The donor cell can come from either
an embryo or an adult. In the case of
mammals, the fused cell is allowed to
divide a few times in vitro before being
implanted into the specially primed
uterus of a surrogate mother. One of
the most difficult aspects of cloning
has been matching the condition of
the donor nucleus with that of the egg,
so that cell division (embryonic cleav-
age) will occur.
What is often forgotten is that the
first cloning was done 40 years ago on
plants, when F.C. Steward of Cornell5
was able to produce entire carrot
plants from single somatic cells (the
kind that we eat). Now in the agricul-
tural world, cloning from somatic cells
is routinely applied for the propaga-
tion of many types of plants. The
vertebrate equivalent of cloning began
with the nuclear transplantation ex-
periments of Briggs and King in 1952,1
and the first production of a vertebrate
animal from an adult nucleus was
accomplished by John Gurdon,2 who
inserted the nucleus from an intestinal
epithelial cell of an adult Xenopus into
an enucleated egg.
Although initially cloning was used
to demonstrate some very important
scientific principles, the principal driv-
ing force behind cloning today is eco-
nomic, a primary goal being the effi-
cient propagation of rare or valuable
species. At this stage of our technol-
ogy, at least, the cloning of an indi-
vidual or armies of humans from a
single super donor in Hitleresque fash-
ion is yet far away, but one learns
‘‘never to say never’’ in the world of
technology. An unknown in present
cloning techniques is the extent to
which the mitochondrial DNA of the
host oocyte affects the phenotype of
the cloned individual. Almost invari-
ably the advent of a major new techno-
logical advance, such as cloning, has
preceded the establishment of an ethi-
cal framework for it, no matter how
long beforehand that advance might
have been anticipated.
Embryonic stem cell technology is
based on older experimental embryo-
logical work showing that individual
cells from the inner cell mass of the
mammalian blastocyst are capable of
forming any cell type in the body. As
pointed out in the following article by
O’Shea,3 this technique involves the
isolation of cells from the inner cell
mass and their propagation in vitro
under conditions that allow them to
remain pluripotent and to reproduce
themselves indefinitely. The goal of
embryonic stem cell technology is to
identify environmental conditions that
will lead the stem cell to differentiate
consistently into a uniform cell type.
At this time, the use of embryonic
stem cells has been a boon to those
who are trying to unravel the molecu-
lar pathways leading to the differentia-
tion of specific cell types. As pure
science, this is in itself a monumental
goal and one that will require an im-
mense amount of experimentation to
attain. Beyond understanding mecha-
nisms of normal cellular differentia-
tion, stem cell technology can be used
to uncover information about the de-
velopment of genetic mutants or about
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the developmental capabilities of cells
that have been genetically engineered.
The holy grail at the end of these lines
of investigation is the production of
non-immunogenic cells that can be
used for the correction of genetic or
pathological cellular deficiencies (e.g.
pancreatic beta cells in diabetics) or
for the replacement of injured or killed
cells and tissues (e.g. necrotic myocar-
dial cells in infarcted regions of the
heart).
Goals such as those outlined in the
previous paragraph are usually consid-
ered laudable by commentators, but
the ultimate source of the embryonic
stem cells is quite controversial, be-
cause they are derived from human
embryonic material. By way of con-
trast, it is not the origin of the cellular
materials but the end product that has
caused the most concern among ethi-
cists and others in cloning experi-
ments. Especially when genetic ma-
nipulation is involved, in either of
these techniques concerns mount, not
so much when somatic cells are the
target, but when the manipulation af-
fects germ cells that could transmit
the manipulations to succeeding gen-
erations.
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